Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 22 Issue 4
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2004  >  (4): 211-212

TANG Jun-da. Protective effect of irbesartan on renal in chronic glomerulonephritis[J]. Journal of Pharmaceutical Practice and Service, 2004, (4): 211-212.
Citation: TANG Jun-da. Protective effect of irbesartan on renal in chronic glomerulonephritis[J]. Journal of Pharmaceutical Practice and Service, 2004, (4): 211-212.
shu

Protective effect of irbesartan on renal in chronic glomerulonephritis

  • Department of nephrology, Hangzhou First People's Hospital, Hangzhou 310006, China

  • Received Date: 2004-02-23
  • Objective To study the effect of irbesartan on decrease proteinuria excretion in chronic glomerulonephritis. Methods:78 cases of chronic glomerulonephritis have taken irbesartan tablets (150mg,qd) to treatment for 12 weeks, and all cases were examined the level of 24-hour-proteinuria before and after treatment 6 weeks,12 weeks. Results After treatment, the level of 24-hour-proteinuria was significantly decreased. The level of proteinuria decreased from 1.86g(before treatment) to 1.46g (after 6 weeks) and 1.18g (after 12 weeks),P<0.01,and the level in 12 weeks was much lower than in 6 weeks(P<0.01). Conclusion Irbesartan has significant effect on decrease proteinuria in chronic glomerulonephritis patients.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2659) PDF downloads(597) Cited by()

Related
Proportional views

Protective effect of irbesartan on renal in chronic glomerulonephritis

  • Department of nephrology, Hangzhou First People's Hospital, Hangzhou 310006, China
  • Received Date: 2004-02-23

Abstract: Objective To study the effect of irbesartan on decrease proteinuria excretion in chronic glomerulonephritis. Methods:78 cases of chronic glomerulonephritis have taken irbesartan tablets (150mg,qd) to treatment for 12 weeks, and all cases were examined the level of 24-hour-proteinuria before and after treatment 6 weeks,12 weeks. Results After treatment, the level of 24-hour-proteinuria was significantly decreased. The level of proteinuria decreased from 1.86g(before treatment) to 1.46g (after 6 weeks) and 1.18g (after 12 weeks),P<0.01,and the level in 12 weeks was much lower than in 6 weeks(P<0.01). Conclusion Irbesartan has significant effect on decrease proteinuria in chronic glomerulonephritis patients.

TANG Jun-da. Protective effect of irbesartan on renal in chronic glomerulonephritis[J]. Journal of Pharmaceutical Practice and Service, 2004, (4): 211-212.
Citation: TANG Jun-da. Protective effect of irbesartan on renal in chronic glomerulonephritis[J]. Journal of Pharmaceutical Practice and Service, 2004, (4): 211-212.
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return